|
(ÁÖ)Å¥¶óƼ½º |
ÀÓ»óÀÎÇã°¡ÆÀ PV Á¤±ÔÁ÷ ¸ðÁý
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
5³â¡è |
ä¿ë½Ã |
06.22 |
|
|
(ÁÖ)»ï¿ÀÁ¦¾à |
Çмú ¸¶ÄÉÆà ¹× ÀÓ»ó¾÷¹« ´ã´çÀÚ °æ·Â»ç¿ø ¸ðÁý
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ó¹Ý±â »ç¿ø¸ðÁý |
3³â¡è |
ä¿ë½Ã |
06.16 |
|
|
GE ÃÊÀ½ÆÄ |
MR Product Sales Specialist
°æ±â ¼º³²½Ã Áß¿ø±¸ | Çз¹«°ü |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
3³â¡è |
ä¿ë½Ã |
03.30 |
|
|
½á¸ðÇǼŻçÀ̾ðƼÇÈ ÄÚ¸®¾Æ |
Sales Operations Analyst, BioProduction Group
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ó¹Ý±â »ç¿ø¸ðÁý |
4³â¡è |
ä¿ë½Ã |
03.29 |
|
|
½á¸ðÇǼŻçÀ̾ðƼÇÈ ÄÚ¸®¾Æ |
Operations Technician, Clinical Trials
¼¿ï °¼±¸ | °íµîÇб³ |
»ó¹Ý±â »ç¿ø¸ðÁý |
3³â¡è |
ä¿ë½Ã |
03.29 |
|
|
½á¸ðÇǼŻçÀ̾ðƼÇÈ ÄÚ¸®¾Æ |
Sales Representative
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ý¸í°øÇÐ/¹ÙÀÌ¿À ¿µ¾÷ |
5³â¡è |
ä¿ë½Ã |
03.29 |
|
|
¾È±¹¹ÙÀÌ¿ÀÁø´Ü(ÁÖ) |
[°æ·Â] ÀÇ·áÁø´Ü ¹× ½Ã¾à ¿µ¾÷ºÎ °ü¸®Ã¥ÀÓÀÚ Ã¤¿ë (¼¿ï)
¼¿ï °¼±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ý¸í°øÇÐ/¹ÙÀÌ¿À ¿µ¾÷ |
10³â¡è |
ä¿ë½Ã |
03.24 |
|
|
(ÁÖ)¶óÆĽº |
(ÁÖ)¶óÆĽº Ç°Áú°æ¿µÆÀ °æ·ÂÁ÷ ¸ðÁý
Ãæ³² õ¾È½Ã | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
5³â¡è |
ä¿ë½Ã |
03.22 |
|
|
Áü¸ÓÄÚ¸®¾Æ |
ÀÇ·á±â±â ¿µ¾÷ (Extremities) °æ·ÂÁ÷ ä¿ë
¼¿ï ¿ë»ê±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
3³â¡è |
ä¿ë½Ã |
03.11 |
|
|
(ÁÖ)ÆÛ½¼ |
ÇØ¿Ü ¿Â¶óÀÎ ¸¶ÄÉÆà °æ·ÂÀÚ Ã¤¿ë
¼¿ï ±Ýõ±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
5³â¡è |
ä¿ë½Ã |
03.08 |
|
|
PPD Korea |
[PPD] ä¿ë°ø°í - Principal Regulatory Affairs Specialist
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
8³â¡è |
ä¿ë½Ã |
03.03 |
|
|
PPD Korea |
[PPD] ä¿ë°ø°í - Home-Based + JOINING BONUS - Sr CRA Opp
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
3³â¡è |
ä¿ë½Ã |
03.03 |
|
|
PPD Korea |
[PPD] ä¿ë°ø°í - Home-Based + JOINING BONUS - Sr CAS Opp
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
SSU |
8³â¡è |
ä¿ë½Ã |
03.03 |
|
|
(ÁÖ)Æ÷ÅØ |
¾È±¤ÇÐ ÀÇ·á±â±â ÇØ¿Ü¿µ¾÷ ¹× ¿µ¾÷°ü¸® ä¿ë
´ëÀü À¯¼º±¸ | °íµîÇб³ |
¹«¿ª/ÇØ¿Ü¿µ¾÷/Åë¹ø¿ª |
7³â¡è |
ä¿ë½Ã |
02.28 |
|
|
PSI CRO Korea |
[PSI CRO Korea] Senior CRA I/II (Moinitori & Lead Monito
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
5³â¡è |
ä¿ë½Ã |
02.21 |
|